Montelukast (sodium) [CAS 151767-02-1]

Montelukast sodium (MK0476) is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1) . Montelukast sodium can be used for the reseach of asthma and liver injury. Montelukast sodium also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast sodium decreases eosinophil infiltration into the asthmatic airways. Montelukast sodium can also be used for COVID-19 research[1][2][3][4].

[151767-02-1]

C35H35ClNNaO3S

608.17

ClC1=CC2=C(C=C1)C=CC(/C=C/C3=CC([C@H](SCC4(CC(O[Na])=O)CC4)CCC5=CC=CC=C5C(C)(O)C)=CC=C3)=N2

Leukotriene Receptor

LTD4/CysLT1

10mM

99.84

DMSO : 50 mg/mL (ultrasonic) |H2O : 50 mg/mL (ultrasonic)

4°C (Powder, sealed storage, away from moisture)

Room Temperature

H318

H318